Y
Yi-Chao Zheng
Researcher at Zhengzhou University
Publications - 76
Citations - 2385
Yi-Chao Zheng is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Cancer & Demethylase. The author has an hindex of 21, co-authored 64 publications receiving 1593 citations. Previous affiliations of Yi-Chao Zheng include Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
Curriculum vitae of HDAC6 in solid tumors.
Yi-Chao Zheng,Huiqin Kang,Bo Wang,Yuanyuan Zhu,Mohammad Ezaz Al Mamun,Longfei Zhao,Haiqian Nie,Yang Liu,Li-Juan Zhao,Xiao-Nan Zhang,Meimei Gao,Dan Dan Jiang,Hong-Min Liu,Ya Gao +13 more
TL;DR: In this paper , a general overview of the structure, biological functions, and mechanism of HDAC6 in solid tumor cells and in the immunological milieu and discuss the preclinical and clinical trials of selective histone deacetylase 6 inhibitors.
Patent
Elastin-like polypeptides (ELP) for prokaryotic expression of fusion protein Prx by non-digestion and non-chromatography purifying method
Liu Hongmin,Zhang Guixing,Wang Xixin,Xuyao Zhang,Long-Zhen Wang,Zhi-Ru Wang,Yuan Jun,Yi-Chao Zheng,Zhao Wen,Zheng Jiaxin +9 more
TL;DR: In this article, the elasticity function of the elastin-like polypeptides (ELP) was improved and the ratio of K, V and F in the fourth basic group in the ELP pentapeptide unit was enabled to be 1: 6: 3.
Journal ArticleDOI
Cover Picture: Fabrication of Predominantly Mn4+‐Doped TiO2 Nanoparticles under Equilibrium Conditions and Their Application as Visible‐Light Photocatalyts (Chem. Asian J. 7/2014)
Lijie Wang,Jiajie Fan,Zetan Cao,Yi-Chao Zheng,Zhiqiang Yao,Guosheng Shao,Guosheng Shao,Junhua Hu +7 more
Journal ArticleDOI
Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
TL;DR: A more comprehensive understanding of DMEs in cancer and cancer therapy is reinforced, and provides more opportunities for cancer therapy.
Journal ArticleDOI
Discovery of the antitumor activities of a potent DCN1 inhibitor compound 383 targeting LSD1 in gastric cancer
Zan Song,Ke-Xin Gao,Moges Dessale Asmamaw,Yue-Jiao Liu,Yi-Chao Zheng,Xiaowei Shi,Hong-Min Liu +6 more
TL;DR: In this paper , a triazolo [1,5-α] pyrimidine-based DCN1 inhibitor compound 383 (IC50 = 11 nM) was reported to selectively inhibit Cullin 3/1 neddylation in MGC-803 cells.